|
240
|
1119
|
7jvcA |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment |
|
233
|
1118
|
7jv4A |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (one rbd open) |
|
253
|
1119
|
7jv6A |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (closed conformation) |
|
189
|
1133
|
7jw0A |
Sars-cov-2 spike in complex with the s304 neutralizing antibody fab fragment |
|
46
|
213
|
7jx3D |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
48
|
198
|
7jx3R |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
59
|
227
|
7jx3C |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
42
|
195
|
7jvaA |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment (local refinement of the receptor-binding domain and fab variable domains) |
|
52
|
215
|
7jx3L |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
16
|
109
|
7jv6D |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (closed conformation) |
|
34
|
195
|
7jmwA |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody cova1-16 fab |
|
4
|
59
|
7jv2A |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody fab fragment (local refinement of the receptor-binding motif and fab variable domains) |
|
26
|
117
|
7jvaH |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment (local refinement of the receptor-binding domain and fab variable domains) |
|
33
|
236
|
7jmwH |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody cova1-16 fab |
|
27
|
214
|
7jvcD |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment |
|
45
|
213
|
7jmwL |
Crystal structure of sars-cov-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody cova1-16 fab |
|
14
|
118
|
7jv4D |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (one rbd open) |
|
30
|
212
|
7jw0C |
Sars-cov-2 spike in complex with the s304 neutralizing antibody fab fragment |
|
25
|
119
|
7jv2H |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody fab fragment (local refinement of the receptor-binding motif and fab variable domains) |
|
23
|
110
|
7jv2L |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody fab fragment (local refinement of the receptor-binding motif and fab variable domains) |
|
22
|
110
|
7jvaL |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment (local refinement of the receptor-binding domain and fab variable domains) |
|
15
|
118
|
7jv6C |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (closed conformation) |
|
16
|
109
|
7jv4E |
Sars-cov-2 spike in complex with the s2h13 neutralizing antibody (one rbd open) |
|
32
|
220
|
7jvcC |
Sars-cov-2 spike in complex with the s2a4 neutralizing antibody fab fragment |
|
28
|
219
|
7jw0D |
Sars-cov-2 spike in complex with the s304 neutralizing antibody fab fragment |
|
48
|
213
|
7jx3B |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
51
|
222
|
7jx3H |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
54
|
228
|
7jx3A |
Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology |
|
44
|
211
|
6xkpL |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-270 |
|
50
|
222
|
6xkqH |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-250 |
|
31
|
177
|
6xkqA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-250 |
|
37
|
194
|
6xkpA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-270 |
|
41
|
230
|
6xkpH |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-270 |
|
41
|
212
|
6xkqL |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cv07-250 |
|
275
|
1121
|
7jwbA |
Sars cov2 spike ectodomain with engineered trimerized vh binder |
|
264
|
1126
|
7k43A |
Sars-cov-2 spike in complex with the s2m11 neutralizing antibody fab fragment |
|
222
|
1119
|
7k4nA |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment |
|
18
|
106
|
7k45L |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment (local refinement of the rbd and fab variable domains) |
|
23
|
122
|
7k45H |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment (local refinement of the rbd and fab variable domains) |
|
25
|
122
|
7k43C |
Sars-cov-2 spike in complex with the s2m11 neutralizing antibody fab fragment |
|
21
|
105
|
7k43D |
Sars-cov-2 spike in complex with the s2m11 neutralizing antibody fab fragment |
|
87
|
421
|
7jwbD |
Sars cov2 spike ectodomain with engineered trimerized vh binder |
|
18
|
120
|
7k4nC |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment |
|
35
|
194
|
7k45B |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment (local refinement of the rbd and fab variable domains) |
|
13
|
103
|
7k4nD |
Sars-cov-2 spike in complex with the s2e12 neutralizing antibody fab fragment |
|
25
|
134
|
6v6wK |
Crystal structure of antibody 438-b11 dss mutant (cys98a-100aa) in complex with an uncleaved prefusion optimized (ufo) soluble bg505 trimer and fab 35o22 |
|
38
|
213
|
6utkE |
Crystal structure of 438-b11 fab in complex with an uncleaved prefusion optimized (ufo) soluble bg505 trimer and fab 35o22 at 3.80 angstrom |
|
29
|
233
|
6v6wF |
Crystal structure of antibody 438-b11 dss mutant (cys98a-100aa) in complex with an uncleaved prefusion optimized (ufo) soluble bg505 trimer and fab 35o22 |
|
68
|
470
|
6utkG |
Crystal structure of 438-b11 fab in complex with an uncleaved prefusion optimized (ufo) soluble bg505 trimer and fab 35o22 at 3.80 angstrom |
|
31
|
240
|
6v6wA |
Crystal structure of antibody 438-b11 dss mutant (cys98a-100aa) in complex with an uncleaved prefusion optimized (ufo) soluble bg505 trimer and fab 35o22 |
